Syntara Limited (ASX:SNT) Presents Interim Data from SNT-5505 Trial
Positive interim data from Syntara Limited’s SNT-5505 trial in myelofibrosis indicates significant clinical potential.
Positive interim data from Syntara Limited’s SNT-5505 trial in myelofibrosis indicates significant clinical potential.
Riversgold Limited (ASX:RGL) has submitted a Mining Lease application for the Northern Zone Gold Project, enhancing its development prospects.
BrainChip Holdings Ltd secures a US$1.8 million contract from the Air Force Research Laboratory for radar signal processing development.
OpenLearning Limited (ASX: OLL) has announced a voluntary suspension of its securities pending a key announcement regarding a related party loan facility.
Korvest Ltd (ASX:KOV) forecasts a record order book and increased project work expected to drive significant profits in FY25.
Korvest Ltd (ASX:KOV) has temporarily paused trading of its securities pending a further announcement.
Immutep Limited (ASX: IMM) has announced the initiation of TACTI-004, a Phase III trial for first-line metastatic non-small cell lung cancer.
Integral Diagnostics receives ACCC clearance for its merger with Capitol Health, expecting implementation by 20 December 2024.
James Bay Minerals (ASX:JBY) announces high-grade copper and silver discoveries at its Independence Project, expanding its exploration targets.
Capitol Health Limited receives ACCC clearance for its proposed merger with Integral Diagnostics, moving closer to final court approval.